VALIDATION OF MR TECH OF THERAPEUTIC EFFICACY FOR DRUG DISCOV IN ALZH DISEASE

$30,257P41FY2011RRNIH

University Of Minnesota, Minneapolis MN

Investigators

Linked publications, trials & patents

Paper 38212349 Paper 37266390 Paper 35012890 Paper 34484102 Paper 33517108 Paper 32951240 Paper 32840468 Paper 32581994 Paper 32472038 Paper 32467648 Paper 32424236 Paper 32187742 Paper 31796137 Paper 31751499 Paper 31471575 Paper 31352813 Paper 31156078 Paper 30394325 Paper 30242896 Paper 30170080 Paper 29152411 Paper 29108528 Paper 29073724 Paper 28698108 Paper 28616384 Paper 27996049 Paper 27981651 Paper 27660604 Paper 27574313 Paper 27498919 Paper 27266965 Paper 27232951 Paper 27114896 Paper 26712657 Paper 26667600 Paper 26656578 Paper 26592718 Paper 26553916 Paper 26534967 Paper 26485382 Paper 26414616 Paper 26373461 Paper 26364023 Paper 26348971 Paper 26287448 Paper 26163815 Paper 26113614 Paper 26098931 Paper 26095521 Paper 26050933 Paper 26001258 Paper 25905715 Paper 25904240 Paper 25892746 Patent RE50920 Patent RE47026 Patent 9915717 Patent 9903928 Patent 9880243 Patent 9841480 Patent 9726742 Patent 9709649 Patent 9689948 Patent 9671481 Patent 9541615 Patent 9341692 Patent 9341691 Patent 9222999 Patent 8941381 Patent 8933698 Patent 8798340 Patent 8750642 Patent 8519707 Patent 8502537 Patent 8212560 Patent 8193809 Patent 8072214 Patent 8067936 Patent 7932719 Patent 7893693 Patent 7800368 Patent 7786729 Patent 7777484 Patent 7710117 Patent 7633293 Patent 7598739 Patent 7514926 Patent 7425828 Patent 7403006 Patent 7279899 Patent 7023209 Patent 6969992 Patent 6958607 Patent 6788056 Patent 6689362 Patent 6650116 Patent 6573714 Patent 6372217 Patent 6073041 Patent 5908386

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Alzheimer's work has focused on two major areas: evaluation of pulse sequences for best detection of amyloid plaques and evaluation of different MR techniques to detect neurodegeneration in genetically modified mice.

View original record on NIH RePORTER →